Skip to content
Alamar Soft-Launch_LP-HERO

 

 

GENEWIZ PROTEOMICS SERVICES

Alamar NULISA™ Technology

Our proteomic services span the full sensitivity range of immuno-affinity protein quantification, now including NULISA technology for ultra-sensitive attomolar detection of low-abundance proteins. By leveraging dual amplification for superior background reduction, this assay provides ~10,000x greater sensitivity than standard immunoassays while requiring minimal sample volume. Enhance your neurology, immunology, and oncology research with our validated workflows as a Certified Service Provider of Alamar's NULISA proteomics platform.

For unrivaled protein analysis, pair Alamar with our Olink® portfolio for seamless integration into your multiomics workflow.
magnifying-glass-icon

Attomolar

ASSAY SENSITIVITY

Detects ultra low abundance proteins missed by conventional immunoassays.

bullseye-arrow-icon

Up to 250

TARGETS PER PANEL

Multiplexed protein quantification for neurology, immunology and oncology targets.

tube-icon

40 µL

SAMPLE TYPES

Plasma, serum, CSF, and select tissue lysates.

CSP logo

Certified Service Provider

CAP AND CLIA PROCESSING

Processing available in our GCP-compliant, CAP-accredited​ and CLIA-licensed laboratory for clinical applications

 

Submit an Inquiry

To chat with one of our experts and learn more about this service, please fill out the form below:

Panel Library

brain-icon-1

Neuro 220 Panel

Includes all CNS 120 panel, targeting ALS, MS, Parkinson’s, and Alzheimer’s.

shield-virus-icon-1

Inflammation 250 Panel

Targeting cardiovascular, autoimmune, metabolic, respiratory, and more.

heart-pulse-icon

Oncology and Autoimmune

Targeted panels for tumor immunity, autoantibody profiling, and low-abundance signaling.

Click to download the full list of protein panels:

Technology Comparison

  Alamar NULISA

OLINK PROXIMITY EXTENSION™ ASSAY (PEA)
Recognition

Dual antibody pair

Dual antibody pair
Signal Mechanism

Sequential capture and release with proximity ligation

Proximity extension with oligonucleotide hybridization
 Readout & Quantitation

NGS (relative or absolute quantitation): NULISA Assays

qPCR (relative or absolute quantitation): NULISAqpcr™ Custom Assays

NGS (relative quantitation): Explore, Reveal

qPCR (relative or absolute quantitation): Target
 Sensitivity Floor

 Attomolar, validated for sub-pg/mL targets

Femtomolar to picomolar, panel dependent
 Sample Volume

40 µL

40 µL
 Best Fit

Neurodegeneration biomarkers, low-abundance target detection, longitudinal monitoring

Discovery, broad biomarker surveys, large cohort screens

 

Applications

  • Neurodegenerative cohort profiling in plasma and CSF

  • Cytokine and IFN signature work in autoimmune and inflammation studies

  • Companion proteomics layered onto bulk RNA-Seq, single cell, or methylation data

  • Low input or precious sample studies where volume is limiting

  • Translational biomarker discovery and verification across phases

The GENEWIZ Difference

checklist-icon-green

Certified Service Provider of Alamar proteomics technology

checklist-icon-green

Flexible turnaround times tailored to meet your project deadlines, whether you need expedited results or a more relaxed timeline

checklist-icon-green

Clinical sample handling, transportation, and processing available for RUO or in our GCP-compliant CLIA and CAP laboratory for clinical applications

checklist-icon-green

Supplemental genomic, transcriptomic, and epigenomic analysis available

checklist-icon-green

Wide variety of sample types accepted